XKON/446440 (XKON/446440)

Korea New Exchange: XKON/446440 · KRW

₩21,950

+2450.00 (+12.6%)· Recorded snapshot

Market cap	48.4B
Revenue (ttm)	449.6M
Net income (ttm)	-5.1B
EPS (ttm)	-₩2,966
Shares out	2.3M
Volume	37
Beta	0.57

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 449.6M
Net income (ttm): -5.1B
EPS (ttm): -₩2,966
Market cap: 48.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-62.7

P25 n/aP50 n/aP75 n/a

ROIC-29.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All XKON/446440 indicators

Market & fundamental data

Available fields

138

Groups with data

Currency

KRW

Showing 138 of 138 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	KRW
Country	South Korea
Country code	KR
Exchange	Korea New Exchange
Financial currency	KRW
First seen	2026-05-10
Fiscal year end	December
Founded	2015
Industry	Biological Products, Except Diagnostic Substances
Is primary listing	Yes
ISIN number	KR7446440000
Last refreshed	2026-10-28
Market cap	KRW 48.4B
Price	KRW 21,950.00
Price currency	KRW
SIC code	2836
Stock price date	2026-10-27
Symbol	xkon/446440
Website	https://epibiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-13.51%
FCF yield	-10.58%
P/B ratio	7.68x
P/S ratio	107.75x
Price / tangible book value	9.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	60.55%
Operating margin	-1,120.59%
Pretax margin	-1,124.91%
ROA	-28.39%
ROCE	-76.75%
ROE	-62.73%
ROIC	-29.34%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue growth	15.93%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	KRW -699.4M
Depreciation and amortization	KRW 744M
EBIT	KRW -5B
EBITDA	KRW -4.3B
EPS	KRW -2,966.00
FCF per share	KRW -2,221.29
Financing cash flow	KRW 1.5B
Free cash flow	KRW -5.1B
Gross profit	KRW 272.2M
Investing cash flow	KRW 3.3B
Net borrowing	KRW -66.7M
Net cash flow	KRW 393.9M
Net income	KRW -5.1B
Operating income	KRW -5B
Revenue	KRW 449.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-3.39
Book value per share	KRW 3,313.83
Debt / equity	0.42
Interest coverage	-55.08
Long-term assets	KRW 5.6B
Long-term liabilities	KRW 259.8M
Net cash (debt)	KRW 851.5M
Net cash / market cap	1.76%
Net debt / equity	-0.14
Piotroski F-Score	1
Property, plant and equipment	KRW 5B
Shareholders' equity	KRW 6.3B
Tangible book value	KRW 5.3B
Tangible book value per share	KRW 3,102.11
Total assets	KRW 9.3B
Total cash	KRW 3.5B
Total debt	KRW 2.6B
Total liabilities	KRW 3B
WACC	7.17%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.04
Current assets	KRW 3.7B
Current liabilities	KRW 2.7B
Current ratio	1.37
Inventory turnover	14.21
Net working capital	KRW -48.4M
Quick ratio	1.29
Working capital	KRW 1B

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	KRW 14,671.80
1D price change	12.56%
1M price change	29.12%
1M total return	29.12%
1W price change	9.75%
1W total return	9.75%
1Y price change	37.19%
1Y return CAGR	37.22%
1Y total return	37.19%
20-day SMA	KRW 17,600.00
200-day SMA	KRW 14,603.15
3M price change	74.48%
3M total return	74.48%
3Y price change	119.72%
3Y return CAGR	30%
3Y total return	119.72%
50-day SMA	KRW 15,366.80
50-day SMA vs 200-day SMA	50over200
52-week high	KRW 21,950.00
52-week high date	2026-10-27
52-week low	KRW 10,880.00
52-week low date	2026-07-20
6M price change	46.33%
6M total return	46.33%
All-time high	KRW 30,000.00
All-time high date	2023-07-31
All-time low	KRW 8,110.00
All-time low date	2024-08-02
Average true range (ATR)	KRW 1,827.47
Average volume	192.4
Beta (1Y)	-0.12
Beta (2Y)	-0.2
Beta (5Y)	0.57
Change from 52-week high	0%
Change from 52-week low	101.75%
Change from all-time high	-26.83%
Change from all-time low	170.65%
Change from open	9.75%
Day's gap	2.56%
Dollar volume	KRW 812,150
High price	KRW 21,950.00
Low price	KRW 20,000.00
Monthly RSI	65.66
Open price	KRW 20,000.00
Position in 52-week range	100%
Previous close	KRW 19,500.00
Price vs 150-day SMA	49.61%
Price vs 20-day SMA	24.72%
Price vs 200-day SMA	50.31%
Price vs 50-day SMA	42.84%
Relative volume	0.19
RSI	68.86
Sharpe ratio	0.68
Sharpe ratio (3Y)	0.54
Sortino ratio	1.09
Sortino ratio (3Y)	0.89
Volume	37
Weekly RSI	66.02
YTD price change	46.33%
YTD total return	46.33%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1M
Shares held by insiders	36.94%
Shares held by institutions	0.32%
Shares outstanding	2.3M

Deeper analysis on XKON/446440

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this XKON/446440 report

Is a complete XKON/446440 research report available?

No complete published report is available for xkon/446440 (XKON/446440) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

XKON/446440 (XKON/446440)

Price

Financial snapshot

Fair-value bridge

Latest news · XKON/446440

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All XKON/446440 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Performance and technicals

Ownership and float

Deeper analysis on XKON/446440

Frequently asked questions